Inflammatory bowel disease (IBD) etiology involves genetic susceptibility, environmental triggers, and the gut microbiome. Antibiotic exposure is associated with IBD, both in early life and adulthood. Here, we investigated whether Nod2-deficiency influenced response of the gut microbiota to antibiotics and subsequent colitis susceptibility. Wild-type and Nod2−/− littermate mice were treated with amoxicillin as adults or neonates, and fecal samples were collected for 16S rRNA sequencing. Five weeks after antibiotic exposure, dextran sulfate sodium (DSS) colitis was induced. Antibiotic treatment altered the microbiota of adult WT and Nod2−/− mice, but recovery was delayed in Nod2−/− mice. Neonatal antibiotic treatment significantly changed the microbiota at weaning in WT and Nod2−/− littermates; however, Nod2−/− mice maintained reduced microbial diversity 14 days after cessation of antibiotics. Although treatment of adult mice did not influence susceptibility to colitis, neonatally treated Nod2−/− mice developed a more severe colitis. Moreover, the colitis phenotype was transferable through fecal transplantation into germ-free Nod2−/− recipients, and was associated with changes in intestinal T cells and the cytokine milieu following inflammation. These data demonstrate that neonatal antibiotic exposure has long-lasting influence on the microbiota and mucosal immunity, and may explain how NOD2 contributes to the risk of intestinal inflammation.
The mammalian gut typically harbors multiple types of microbes, including ~4 × 1013 bacteria,1 in a dynamic community whose structure depends on environmental and host genetic influences.2,3,4,5,6 Maintaining this symbiotic relationship is key to the balance between health and disease. Colonization of the gut microbiota during neonatal life influences the development of the mucosal immune system.7 Environmental perturbations during this critical window can alter the ‘normal’ development of the gut microbiota and the mucosal immune system, possibly increasing susceptibility to disease. Indeed, mouse and human studies suggest that neonatal antibiotic exposure is associated with an increased risk of inflammatory diseases, including asthma,8 obesity9, and inflammatory bowel disease (IBD).10,11,12 This is supported by observations that early life and repeated antibiotic exposure significantly increases the risk for developing IBD.11,13
Given that Nod2 mutations are one of the most important genetic risks for the development of Crohn’s disease, we investigated whether Nod2-deficiency altered the impact of antibiotic exposure on microbiota composition and susceptibility to colitis. We found that Nod2 influenced microbial resilience following adult and neonatal antibiotic treatment. Although the adult treatment did not alter colitis susceptibility, neonatal antibiotic treatment resulted in increased colitis severity in Nod2−/− mice. Moreover, transfer of the neonatal antibiotic-microbiota increased colitis severity in germ-free recipients. This phenotype was associated with altered cytokines and increased colonic Gata3+Foxp3+ regulatory T cells. This suggests that the sustained alterations of the gut microbiota following neonatal antibiotic exposure combined with the absence of Nod2 signaling during mucosal barrier breach results in exacerbated mucosal damage.
Nod2 genotype influences microbiota resilience after antibiotic exposure in adult mice
We first investigated how a single course of the broad-spectrum antibiotic, amoxicillin, altered the adult murine microbiota, and whether Nod2 genotype influenced this perturbation. Adult WT and Nod2−/− littermate mice were given amoxicillin-supplemented water for 7 days and stool samples were collected at day 0 (pre-treatment) and on day 7 (Fig. 1a). In order to further assess whether Nod2 influenced the resilience or recovery of the microbiota following antibiotic exposure, stool was collected on day 21, i.e., 14 days after stopping antibiotic-supplemented water. Each mouse was compared to its pre-treatment composition (day 0) and water-treated littermate controls. Using 16S rDNA sequencing, microbial diversity was evaluated for species richness (as measured by the Chao1 rarefaction index) and beta diversity (as measured by Bray–Curtis dissimilarity, which factors in presence/absence and relative abundance of operational taxonomic units).
As previously described,14 Nod2 genotype was not associated with any difference in the microbiota in terms of species richness, beta diversity, or composition at day 0 (Fig. 1b–d), indicating that Nod2-deficiency alone was not sufficient to alter microbial colonization. Antibiotic treatment shifted the microbial community away from pre-treatment composition in both WT (R = 0.6778, p = 0.001) and Nod2−/− (R = 0.7922, p = 0.001) littermates at day 7 (Fig. 1b, c). This was characterized by reduced species richness (Fig. 1b), and loss of taxa including Erysipelotrichaceae, Clostridiales, and Lactobacillaceae, with corresponding increases in Enterobacteriaceae and Bacteroidaceae (Fig. 1d). Thus, the microbiota of both adult WT and Nod2−/− mice was significantly altered by a seven-day course of amoxicillin treatment.
Recovery of the microbiota following antibiotic treatment was assessed on day 21. Antibiotic-treated WT and Nod2−/− mice maintained a significantly different microbiota than pre-treatment composition (WT: R = 0.1494, p = 0.013, Nod2−/−: R = 0.2144, p = 0.001; Fig. 1c). Moreover, species richness at day 21 was significantly lower than pre-treatment richness for both genotypes (Fig. 1b). In order to further determine which bacterial taxa contributed to the differences both statistically and biologically, we utilized linear discriminant analysis (LDA) effect size (LEfSe) analysis.15 LEfSe analysis comparing the microbiota at day 0 vs. 21 of antibiotic-treated WT mice identified taxa that differed in abundance following antibiotic treatment (Fig. 1e, left panel). Taxa that were reduced or absent at day 21 compared to day 0 included Erysipelotrichaceae, Rikenellaceae, and Odoribacteraceae. Taxa enriched at day 21 compared to day 0 included Bacteroides and Bilophila. These compositional changes were induced by the antibiotic treatment and failed to resolve by day 21. Many of these taxa changes were shared in both antibiotic-treated WT and Nod2−/− mice, however, there were differences between the genotypes. LEfSe analysis of antibiotic-treated Nod2−/− mice further identified several taxa that differed between day 0 and 21 only in Nod2-deficient mice (Fig. 1e, right panel), including expansion of Gammaproteobacteria and Desulfovibrionaceae on day 21. Moreover, at day 21, antibiotic-treated Nod2−/− mice were enriched for the Gammaproteobacteria Enterobacteriaceae and had lost the family of Mogibacteriaceae compared to WT mice. These taxonomic differences due to antibiotic treatment were further highlighted using Euclidean distance and centroid linkage clustering analysis (Fig. 1f). These data suggest that Nod2 influenced both the changes in microbes in response to antibiotic treatment, and the resilience or recovery of the microbiota in adult mice.
Nod2 influences microbial response to antibiotic treatment during the neonatal period
We next investigated the impact of Nod2 genotype on the microbiota response to antibiotic treatment during the neonatal period (from birth until weaning—day 21 after birth), since environmental exposures significantly influence development of the intestinal microbiota in early life.16 Following birth, dams and newborn pups received water supplemented with amoxicillin, provided ad libitum until the age of weaning (Fig. 2a). Microbiota composition was assessed in stool samples collected at weaning (day 21). In order to monitor the maturation and recovery of the microbiota, stool samples were also collected on day 35 (14 days after weaning and cessation of antibiotic treatment). As observed in the adult treatment, neonatal antibiotic exposure resulted in a significant shift of the microbial community composition away from that in water-treated litters at day 21 (Supplementary Figure 1A). Although there was minimal variability within water-treated litters, there was significantly greater variability within antibiotic-treated litters, as measured by Bray–Curtis dissimilarity distance (Supplementary Figure 1B). The distance between water and antibiotic-treated litters was the greatest, emphasizing the community perturbation induced by antibiotic treatment. Thus, early life antibiotic exposure significantly altered the gut microbiota at weaning.
We then examined the influence of Nod2 genotype on the response of gut microbiota to early life antibiotic exposure. Diversity, as assessed using the Chao1 index of OTU richness, at weaning was not different between water-treated WT and Nod2−/− littermates; however, community richness was significantly diminished in antibiotic-treated WT and Nod2−/− mice at weaning (Fig. 2b). Moreover, the microbial communities of antibiotic-treated WT and Nod2−/− littermates were significantly different from that of their water-treated genotype-matched controls on day 21 (WT vs. WT+Abx: R = 0.5229, p = 0.001; Nod2−/− vs. Nod2−/−+Abx: R = 0.4929, p = 0.001; Fig. 2c). Antibiotic treatment reduced the relative abundance of Bifidobacteriaceae, Lactobacillaceae, Lachnospiraceae, and Erysipelotrichaceae, and induced a bloom of Bacteroidaceae in both WT and Nod2−/− mice (Fig. 2d, Supplementary Table 1-3). Several important differences were observed in the response to antibiotic treatment at weaning between Nod2−/− and WT littermates. Specifically, antibiotic-treated Nod2−/− mice experienced a decrease of Coriobacteriaceae, Rikenellaceae, S24-7, Paraprevotellaceae, Ruminococcaceae, and a bloom of Enterobacteriaceae compared to Nod2−/− water-treated controls (Fig. 2d, Supplementary Table 3); antibiotic-treated WT mice only had elevated relative abundance of Verrucomicrobiaceae compared to water-treated WT controls (a change not observed in the antibiotic-treated Nod2−/− mice) (Supplementary Table 2). These data suggest a role for Nod2 in shaping the response of certain bacterial taxa to antibiotic perturbation.
Absence of Nod2 signaling influences the resilience of gut microbiota two weeks after neonatal antibiotic exposure
We sought to determine whether neonatal antibiotic-induced changes in the microbiota resolved 14 days after weaning. Antibiotic treatment was stopped at weaning and stool samples were collected on day 35 after birth (14 days post weaning) (Fig. 2a). No differences in microbiota diversity or composition were observed between water-treated WT and Nod2−/− littermates (R = 0.0199, p = 0.250, Supplementary Table 4), or between water and antibiotic-treated WT mice on day 35 (R = 0.1322, p = 0.091; Fig. 2c, Supplementary Table 5), suggesting that the gut microbiota of WT mice had recovered 14 days after cessation of antibiotics.
In contrast, the microbiota in antibiotic-treated Nod2−/− mice failed to recover, in that there was a significantly different community compared to water-treated Nod2−/− controls (R = 0.3726, p = 0.001; Fig. 2c). This was evident in the Chao1 index comparisons with antibiotic-treated Nod2−/− mice having lower richness (Fig. 2b) than their water-treated controls at day 35. Specifically, Nod2−/− mice that received antibiotic treatment had persistently increased relative abundance of Porphyromonadaceae, and decreased levels of Bifidobacteriaceae, Rikenellaceae, and Erysipelotrichaceae compared to their water-treated controls (Fig. 2d, Supplementary Table 6).
In order to better describe the strength and direction of the taxonomic changes induced by neonatal antibiotic treatment and the influence of Nod2 genotype, LEfSe analysis was performed. As described above, all of the antibiotic-induced differences between water and antibiotic-treated WT mice at weaning were also observed in Nod2−/− mice, including a reduction in Lactobacillaceae and Bifidobacteraceae (Fig. 3a). On the other hand, Nod2−/− mice showed additional changes in several bacterial families, including decreased relative abundance of Rikenellaceae, S24-7 and Christensenellaceae (Fig. 3a, indicated with a *). Direct comparison of antibiotic-treated WT and Nod2−/− mice further highlighted microbial differences related to host genetics, primarily expansion of Flexispira and an unspecified genus of Enterobacteriaceae, along with diminished abundance of Akkermansia, Parabacteroides, and Adlercreutzia (Supplementary Figure 1C). Together, these data suggest a role for Nod2 in shaping the microbial changes at weaning in response to neonatal antibiotic exposure.
LEfSe analysis of the microbiota on day 35 further highlighted the differential response to and recovery from antibiotic treatment in Nod2-deficient mice (Fig. 3b), including increased Prevotellaceae and Lactobacillaceae, and decreased Clostridaceae, compared to water-treated controls. Comparison between antibiotic-treated WT and Nod2−/− littermates emphasized the loss of Erysipelotrichaceae and over-abundance of Coriobacteriaceae in the Nod2−/− mice as the strongest differences between the genotypes (Supplementary Figure 1D). Clustering analysis further supported these findings (Fig. 3c). Together, Nod2-deficiency was associated with residual changes in the microbiota and a failure to fully recover to the composition and diversity of water-treated mice. These data suggest that Nod2 not only influences the specific response of the microbiota to antibiotic treatment, but also influences the recovery, suggesting that microbial changes may persist long after the antibiotic perturbation.
Adult antibiotic exposure fails to increase susceptibility to DSS colitis
Antibiotic exposure has been associated with IBD development, however the mechanism remains unclear. Given that a seven-day course of antibiotics had long-lasting impact on the gut microbiota of adult Nod2−/− mice, we assessed whether this perturbed microbiota altered susceptibility to or severity of experimental colitis. Colitis was induced in adult mice 4 weeks after completion of antibiotic treatment (Supplementary Figure 2A). Water and antibiotic-treated WT and Nod2−/− littermates were subjected to DSS-supplemented drinking water for 5 days. Individual body weight was recorded and the level of lipocalin-2 (Lcn-2) (an anti-microbial peptide produced by neutrophils and epithelial cells and released during intestinal inflammation17) in stool was measured on day 0, 3, and 5 of DSS treatment. DSS exposure resulted in significant weight loss, which was not altered by Nod2 genotype or antibiotic exposure (Supplementary Figure 2B). Lipocalin-2 was also significantly increased in DSS-treated mice, but no differences were identified between genotypes or antibiotic treatment (Supplementary Figure 2C). Colon length and pathological colitis score further supported no effect of antibiotic exposure on severity of DSS colitis in WT or Nod2−/− littermate mice (Supplementary Figure 2D-F). These data suggest that although microbiota of adult Nod2−/− mice had delayed resilience following antibiotic treatment, there was no effect on susceptibility or severity to DSS-induced mucosal damage.
Neonatal antibiotic treatment increases susceptibility to DSS colitis 35 days after antibiotics in Nod2 −/− mice
We next assessed whether the neonatal antibiotic treatment had an effect on susceptibility to DSS-induced colitis. As described above, at weaning mice were placed on normal drinking water for 5 weeks, and colitis was initiated on day 56 (Fig. 4a). Starting on day 56 (day 0 of disease induction), mice were fed DSS-supplemented drinking water for 5 days followed by a 2-day rest on regular drinking water and tissues were analyzed on day 64. DSS caused water-treated WT and Nod2−/− mice and antibiotic-treated WT mice to lose ~10% of their initial body weight by day 8, whereas antibiotic-treated Nod2−/− mice lost over 20% of starting weight (Fig. 4b). Stool collected on days 0, 3, 5, and 8 was used to quantify fecal lipocalin-2 concentration. Corresponding with the increased weight loss, antibiotic-treated Nod2−/− had elevated lipocalin-2 concentration at days 5 and 8 reflecting more significant inflammation (Fig. 4c). Furthermore, antibiotic-treated Nod2−/− mice had greater colonic shortening compared to water-treated Nod2−/− mice and antibiotic-treated WT littermates (Fig. 4d). Pathological scoring also indicated increased tissuedamage and inflammatory cell depth in antibiotic-treated Nod2−/− mice compared to WT littermates (Fig. 4e, f). No differences in colitis susceptibility or severity were observed between water-treated and antibiotic-treated WT mice, nor were differences observed between water-treated WT and Nod2-deficient littermates, indicating that the antibiotic perturbation in early life, combined with a Nod2-deficiency, resulted in worsened disease.
Next, we sought to determine whether the microbiota was having a causal role in the increased colitis severity. Cecal microbiota was collected at weaning from water or antibiotic-treated Nod2−/− mice and transplanted into age-matched germ-free Nod2−/− recipients. Colitis was induced in the recipients at 8 weeks of age (day 56) (Fig. 5a). Both male and female recipients of the antibiotic-treated microbiota (A-MB) weighed more than their counterparts who received water-treated microbiota (W-MB) on day 56 (Fig. 5b), supporting previous studies that showed an effect of antibiotic exposure on weight gain.18 Although both A-MB and W-MB recipients lost ~10% body weight following DSS exposure (Fig. 5c), A-MB recipients had significantly increased fecal lipocalin-2 on day 5 and 8 and shorter colons indicating more severe damage (Fig. 5d, e). Together, this demonstrates that the antibiotic-altered microbiota was sufficient for the development of a more severe DSS-induced colitis in the germ-free Nod2−/− recipients.
Colonic regulatory T cells are induced by altered gut microbiota and regulate colitis
Regulatory T cells (Treg) are involved in controlling and limiting gut inflammation and can be induced through microbial interactions.19,20,21,22,23 We postulated that differences in Treg could be involved in the increased susceptibility to DSS observed in the neonatal antibiotic-treated Nod2−/− mice and the A-MB gnotobiotic recipients. In order to address this, we performed flow cytometry on small intestinal and colonic lamina propria lymphocytes from neonatal water-treated and antibiotic-treated WT and Nod2−/− littermates at 8 weeks of age. There were no differences in total lymphocytes isolated or in the percent of CD3+ T cells between genotypes and treatments (Fig. 6a). RORγt+ T cells, Foxp3+ regulatory T cells, and RORγt+Foxp3+ double positive Treg were significantly increased in the small intestine of mice previously treated with antibiotics compared to water controls (Fig. 6a). Interestingly, although the RORγt+ T cell populations were similar in the small intestine and colon, the Treg increases were only seen in the colonic lamina propria of Nod2-deficient littermates, although there was a trend for increases in the antibiotic-treated WT littermates. These T cell populations are known to be induced via host–microbe interactions.24
We next explored the effect of DSS-induced damage on colonic T cell populations. DSS exposure induced an increase in Foxp3+ Treg in the colon of water-treated Nod2−/− mice but did not further increase the already elevated population in antibiotic-treated mice. RORγt+Foxp3+ double positive Treg were significantly diminished in the DSS-exposed, antibiotic-treated mice, and in water-treated Nod2−/− mice compared to WT littermates (Fig. 6b). Coinciding with the reduction in RORγt+Foxp3+ double positive Treg, we detected a significant increase in Gata3-expressing Foxp3+ Treg in antibiotic-treated Nod2−/− mice following DSS exposure that was not observed in antibiotic-treated WT mice or water-treated controls (Fig. 6b).
Analysis of the colonic lymphocytes from W-MB and A-MB Nod2−/− recipients showed no differences in the proportions of CD3+, RORγt+, Foxp3+, or RORγt+Foxp3+ T cells between A-MB and W-MB recipients (Fig. 6c, open bars). However, although W-AB recipients had no Gata3+Foxp3+ Treg, A-MB recipients had ~4% of Treg co-expressing Gata3+ and Foxp3+. DSS-induced colitis caused an increase in the proportion of CD3+ T cells, but reduced RORγt+, Foxp3+, and RORγt+Foxp3+ T cells in both W-MB and A-MB recipients (Fig. 6c, shaded bars). Although the reduction of RORγt+Foxp3+ Treg in the gnotobiotic recipients is similar to what was observed in the SPF mice, there was no coinciding expansion of Gata3+Foxp3+ Treg after DSS. Thus, while transfer of antibiotic-treated microbiota was sufficient to recapitulate the increased colitis phenotype observed in Nod2−/− mice, the effect on mucosal Treg was not the same, possibly due to the use of the germ-free colonization model. Indeed, it is difficult to ascertain whether the differences were due to the colonization timing, or were secondary phenomena following DSS-induced mucosal damage.
DSS exposure alters the colonic cytokine milieu of Nod2 −/− mice with neonatal antibiotic-treated microbiota
In order to examine the cytokines involved in the DSS response and possibly influencing the change in Treg response, mRNA from the proximal colon of water and antibiotic-treated Nod2−/−, as well as W-MB and A-MB recipient Nod2−/− mice, was analyzed. DSS-induced colitis resulted in increased expression of the pro-inflammatory cytokines IL1β and IL6 in both water and antibiotic-treated Nod2−/− mice, with a further increase in IL6 expression in antibiotic-treated mice (Fig. 7a), complementary to the increased weight loss and pathology observed. Expression of the anti-inflammatory cytokine IL10 was also induced with DSS exposure, but no difference was detected between water and antibiotic-treated mice (Fig. 7a). Interestingly, A-MB recipients had increased expression of IL1β compared to W-MB recipients in the absence of inflammation; however, the intense damage induced by DSS resulted in increased IL1β and IL6 in both W-MB and A-MB recipients (Fig. 7b). Expression of IL10 was only significantly increased in A-MB recipients.
Gata3 expression in Foxp3+ Treg can be induced through the cytokines IL-4, TGFβ and IL-33. Indeed, the proportion of Foxp3+ Treg expressing Gata3 was significantly increased in antibiotic-treated Nod2−/− mice exposed to DSS and A-MB recipients (Fig. 6b, c). Expression of both IL10 and TGFβ contribute to Treg maintenance, and enhanced IL4 and IL33 expression suggests that the cytokine milieu favored the generation and support of Gata3+Foxp3+ Treg during DSS colitis in antibiotic-treated Nod2−/− mice (Fig. 7a). Although no differences in IL4 and TGFβ expression were detected in W-MB or A-MB recipients, IL33 expression was significantly increased in A-MB mice after DSS (Fig. 7b). Thus, the cytokine milieu is influenced by both the gut microbiota and DSS-induced inflammation. Coinciding with the macroscopic and T cell changes observed, DSS colitis combined with an antibiotic-altered microbiota resulted in increased expression of pro-inflammatory cytokines and favored the expansion of a unique population of Gata3+Foxp3+ Treg.
Together, our data show that neonatal antibiotic treatment can alter the gut microbiota long-term and influence colitis susceptibility in a Nod2-deficient host. Although Nod2 alters the response of the gut microbiota to antibiotics in adult mice, this fails to increase colitis susceptibility, suggesting that the timing of the antibiotic exposure is key to the influence of the microbial changes on the mucosal immune response.
In this study, we investigated the effect of antibiotic treatment on the composition and diversity of the gut microbiota and whether Nod2, the strongest IBD genetic risk association and a microbial sensor, influenced the response. We found that Nod2-deficient mice had prolonged microbial perturbation following antibiotic treatment, both as neonates and adults. Although adult antibiotic treatment had no effect on DSS colitis, Nod2−/− mice that were exposed as neonates were more susceptible to colitis, with increased weight loss and mucosal damage. Colonization of germ-free Nod2−/− mice with neonatal antibiotic-treated microbiota resulted in worsened colitis compared to recipients of water-treated microbiota. Together, these data illustrate the broad and long-lasting effects of antibiotic perturbation of the microbiota in early life, and how host genetics can alter these effects and lead to increased susceptibility to colitis. Moreover, these data indicate that Nod2 has a critical role in shaping gut microbial responses and resilience to perturbations.
Antibiotic exposure transiently changes the gut microbiota in humans;25,26 however, the microbiota is usually resilient, returning to pre-treatment composition shortly after removal of the antibiotic for most subjects.25,27 Alterations in the microbiota of both antibiotic-treated neonatal and adult Nod2−/− mice were maintained 14 days after the removal of antibiotic treatment suggesting a reduced resilience. Our study is the first to identify a role for Nod2 in microbial resilience following an antibiotic perturbation.
Neonatal antibiotic exposure has been associated with several auto-inflammatory diseases including asthma, obesity, and IBD.8,9,11 In humans, the microbiota is highly malleable until 2–3 years of age.3,28 In order to model the effects of repeated antibiotic exposure during the first years of an infant’s life (but not influence the original inoculum that birth provides), we developed an antibiotic treatment regime, starting after birth until weaning, using the most commonly prescribed antibiotic to pediatric patients, amoxicillin.29 The broad-spectrum beta-lactam, effective against Gram- negative and positive bacteria, also passes through breast milk, making it an ideal candidate for antibiotic exposure to pups that avoids the stress and potential concomitant alterations of the microbiome due to handling.30,31 We found that amoxicillin treatment caused a significant shift in the community structure of the gut microbiota in mice at weaning, with reduced bacterial richness and diversity. Antibiotic treatment resulted in loss of Bifidobacteriaceae, Lactobacillaceae, Lachnospiraceae, and Erysipelotrichaceae, whereas Bacteroidaceae and Enterobacteriaceae bloomed. These changes are in agreement with antibiotic-induced alterations observed previously in both humans and mice.18,28,32,33 Specifically, the maintained loss of Lachnospiraceae and expansion of Porphyromonadaceae following antibiotic treatment was also observed in a longitudinal study in children followed from birth until 2 years of age.32
Corroborating previous work by our team, there was no effect of Nod2 genotype on the stool microbial composition between water-treated littermates.14 However, we identified several differences in the microbiota between antibiotic-treated WT and Nod2−/− littermates, in both adult and neonates. Antibiotic-treated Nod2−/− mice displayed a persistent loss of Erysipelotrichaceae and increased levels of Prevotellaceae two weeks after removal of the antibiotic treatment. The idea of a ‘pro-colitogenic’ microbiota in Nod2-deficient mice has been described previously;34,35,36 however, those studies used non-littermate mice and so the exact influence of Nod2 on the microbiota and colitis susceptibility is not clear. We used littermate mice in order to assess the specific influence of Nod2 genotype on the gut microbiota and responses to antibiotic perturbation, while controlling and normalizing other environmental influences.37 The microbiota transfer experiment highlights the influence of Nod2 genotype on the microbiota, since Nod2-deficient recipients of the A-MB were more susceptible to colitis; however, it remains to be shown whether this is due to the influence of Nod2 genotype on the donor microbiota versus on the recipient’s response to the altered microbes. Although direct comparisons to human data cannot be made, this study emphasizes the role of host genetics on shaping the gut microbiota in response to environmental perturbations.
We examined the effects of prior antibiotic exposure on colitis susceptibility and severity. First, the DSS model was utilized to induce colitis in mice that received antibiotic treatment as adults, however no effect of genotype or treatment was observed on susceptibility or severity. This is consistent with previous findings showing that Nod2-sufficient and deficient littermates do not differ in response to DSS,38 but contradicts other papers where non-littermate mice (with different gut microbiota) showed increased susceptibility of Nod2−/− to DSS-induced colitis.34,39 On the other hand, neonatal antibiotic treatment of Nod2−/− littermates resulted in worsened colitis, characterized by increased weight loss and mucosal damage. The difference in colitis susceptibility between the adult and neonatal antibiotic treatment within the same littermate colony indicates that the time of the exposure is critical for how the immune system responds to microbial perturbations. Some studies have successfully described the effects of different classes of antibiotics on the gut microbiota in children,28,40 and others have gone on to implicate these changes with disease development later in life.41 Recently, two groups reported similar studies assessing the effects of peripartum antibiotic exposure or transfer of antibiotic-altered microbiota in the IL−10−/− model of colitis.12,42 These two studies also observed that antibiotic-altered gut microbes resulted in increased susceptibility to colitis. Although the IL-10−/− model is an excellent mouse model for assessing microbially driven inflammation (as mice do not develop disease when maintained germ-free,43) mutations in the IL-10 pathway results in severe immune dysregulation and very early onset-IBD (VEO-IBD) in humans.44 Since NOD2 mutations have the strongest genetic-risk association with IBD and as a cytosolic microbial receptor, our study provides a unique look at the influence of IBD-related host genetics on the response to antibiotic exposure, the resilience of the microbiota and susceptibility to colitis.
Antibiotic treatment increased intestinal T cell populations involved in host–microbe interactions, including Treg, Th17, and RORγt+Foxp3+ Treg. In contrast to a study that found that neonatal vancomycin treatment reduced colonic Foxp3+ Treg,45 our neonatal amoxicillin treatment increased intestinal Foxp3+ Treg populations. Our findings point to the idea that the development of intestinal Treg may be complex and tightly linked to the gut microbiota. Induction of non-classical Treg, including RORγt+Foxp3+ and Gata3+Foxp3+ Treg, in our antibiotic-treated mice indicates the important influence of microbes on the maturation of these cells. Indeed, previous studies have suggested that these cells are generated in response to the gut microbiota.46,47 RORγt+Foxp3+ Treg develop from Foxp3+ Treg,48 and are functionally equivalent, if not superior, to Foxp3+ Treg in protecting against inflammation in the T cell transfer model of colitis.49 By contrast, Gata3+Foxp3+ Treg are driven by IL-33 released during barrier disruption, mediate tissue damage,50 and are thought to be involved with controlling inflammation and mucosal damage.51,52 Previously, these cells were shown to not differ in abundance between germ-free and SPF WT mice;53 however, whereas the A-MB Nod2−/− recipients had colonic Gata3+Foxp3+ Treg, the W-MB recipients had none. This difference in findings may indicate that these cells can be microbially induced. Together, this suggests that the altered intestinal T cell populations following neonatal antibiotic treatment can result in dysregulated immune responses and worsened colitis in a genetically susceptible host.
Antibiotic exposure is associated with increased risk for IBD development, however the differences in the gut microbiota between individuals make it difficult to ascertain the causal effect of antibiotic exposure. Using a controlled animal model, we identified that Nod2-deficiency resulted in delayed resilience of the gut microbiota following adult and neonatal antibiotic treatment; however, only Nod2−/− mice exposed as neonates experienced an increased severity of colitis indicating that time of exposure is critical. Collectively, our data highlight the long-lasting influence of an altered neonatal microbiota on mucosal immune homeostasis and development of disease.
Materials and methods
Wild-type (WT), Nod2−/−, and Nod2+/- littermates (on a C57BL/6 background) were bred in-house under specific pathogen-free conditions. Littermate breeders were maintained in heterozygous (Het) × Het crosses, using sister dams, whenever possible. Mice received breeder chow (Teklad® irradiated Rodent Chow #2919; Envigo, Huntingdon, UK) and autoclaved drinking water (pH ~7) ad libitum. All mice were housed on the same rack within the facility and received normal chow (Teklad® irradiated Rodent Chow #2918; Envigo) and autoclaved drinking water (pH ~7) ad libitum from weaning to endpoint.
Germ-free Nod2-deficient mice were kindly provided by Drs. Jon Schertzer and Elena Verdu from McMaster University, Hamilton, Ontario, Canada.
All experiments were performed in accordance with University of Toronto’s Department of Comparative Medicine approved animal use protocols.
Antibiotic (Abx)-treated mice received amoxicillin (BioShop, Burlington, Canada) at 200 mg/L in autoclaved drinking water (pH ~7). Adult treatment started at 8 weeks of age and was maintained for 7 days (Figs. 1a and 2a). Neonatal treatment started one day after birth and was maintained until weaning (day 21), followed by autoclaved drinking water from weaning to endpoint (Fig. 3a). Bottles were refreshed every other day. Water-treated mice received autoclaved drinking water for the duration of all experiments.
16S sequencing and analysis
The V4 hypervariable region of bacterial 16S ribosomal DNA (16S rDNA) was sequenced in paired-end modus (2 × 150 base pair) on the MiSeq platform (Illumina, San Diego, CA) using primers 515F/806R.54 The resulting paired reads were assembled using PANDAseq v 2.7 to generate an amplicon size of 250 base pairs.55 Sequences were de-multiplexed and processed by the quantitative insights into microbial ecology (QIIME v1.8.0) pipeline using default parameters.56 The mean number of quality-controlled reads was 72,760 ± 33,893 (mean ± SD) per mouse sample. Chimeric sequences were identified de novo, reference-based and then removed using usearch61.57 The non-chimeric sequences were then clustered into operational taxonomic units (OTUs) at 97.0% sequence similarity using a closed reference-based picking approach with UCLUST software against Greengenes database 13_8 of bacterial 16S rRNA sequences.58 After rarefaction at 10,000 reads per sample, bacterial alpha diversity was estimated using the Chao1 and Shannon diversity indices. Samples with fewer than 10,000 reads after quality filtering were removed from the analysis. OTUs with a prevalence < 5% were removed from the analysis. Analyses using R software v2.14.1 were restricted to merged OTUs with the same taxonomic assignment. A paired Student’s t-test was applied to compare the alpha diversity differences in microbial profiles in WT and Nod2−/− mice, and between antibiotic and untreated groups. Relative abundance of taxa in microbial profiles in WT and Nod2−/− mice was compared using the Kruskal–Wallis test. Associations between bacterial taxa and groups were considered to be significant after a false-discovery rate (FDR) correction of the p-value (q < 0.05). Beta diversity was assessed using Bray–Curtis dissimilarity distances. Procrustes analyses based on Bray–Curtis distance was applied to compare microbial orientation differences following antibiotic treatment and a Monte Carlo simulation was performed using 10,000 permutations on the first five dimensions of the PCoA. Microbial community similarity between the different groups of mice was addressed by performing an ANOSIM test with 10,000 permutations on the beta-diversity metrics described above on the first five dimensions of the PCoA.
Cecal contents from water-treated or antibiotic-treated Nod2−/− littermates were harvested anaerobically at weaning and diluted 1/10 in 50% glycerol. Germ-free C57BL/6 Nod2−/− mice were bred in-house at the University of Toronto Gnotobiotic facility. At weaning, under strict aseptic conditions, germ-free mice were transferred into the specific pathogen-free facility and colonized with 150 μL of the cecal content slurry. Colitis was induced 5 weeks post-colonization.
Results are depicted as mean ± SEM, unless otherwise indicated. Statistical analysis was performed using one-way or two-way analysis of variance with post hoc Tukey or Holm–Šídák test, Mann–Whitney U test, or Kruskal–Wallis test, as specified. Differences between groups were considered significant when p < 0.05. For all statistical comparisons, *p < 0.05, **p < 0.01 ***p < 0.001, ****p < 0.0001, and NS means not significant. Calculations were performed using GraphPad Prism 7.0 software (GraphPad, La Jolla, CA).
Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220–230 (2012).
Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
Faith, J. J. et al. The long-term stability of the human gut microbiota. Science 341, 1237439 (2013).
Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260–270 (2012).
Turpin W., et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat. Genet. 48, 1413–1417 (2016).
Tamburini, S., Shen, N., Wu, H. C. & Clemente, J. C. The microbiome in early life: implications for health outcomes. Nat. Med. 22, 713–722 (2016).
Marra, F. et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics 123, 1003–1010 (2009).
Scott, F. I. et al. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology 151, 120–129 (2016).
Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R. & Coffin, S. E. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794–803 (2012).
Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol. 105, 2687–2692 (2010).
Miyoshi, J. et al. Peripartum antibiotics promote gut dysbiosis, loss of immune tolerance, and inflammatory bowel disease in genetically prone offspring. Cell Rep. 20, 491–504 (2017).
Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49–54 (2011).
Robertson, S. J. et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4, 222–231 (2013).
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
Spor, A., Koren, O. & Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279–290 (2011).
Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS ONE 7, e44328 (2012).
Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705–721 (2014).
Round, J. L. & Mazmanian, S. K. Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204–12209 (2010).
Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).
Feng, T., Elson, C. O. & Cong, Y. Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota. Int. Immunopharmacol. 11, 589–592 (2011).
Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).
Tanoue, T. & Honda, K. Induction of Treg cells in the mouse colonic mucosa: a central mechanism to maintain host-microbiota homeostasis. Semin. Immunol. 24, 50–57 (2012).
Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323 (2009).
Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6, e280 (2008).
Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255–1265 (2018).
Dethlefsen, L. & Relman, D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. USA 108(Suppl 1), 4554–4561 (2011).
Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci. Transl. Med. 8, 343ra381 (2016).
Chai, G. et al. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 130, 23–31 (2012).
De Palma, G. et al. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun. 6, 7735 (2015).
Moussaoui, N. et al. Chronic early-life stress in rat pups alters basal corticosterone, intestinal permeability, and fecal microbiota at weaning: influence of sex. J. Neurogastroenterol. Motil. 23, 135–143 (2017).
Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. 8, 343ra382 (2016).
Russell, S. L. et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13, 440–447 (2012).
Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700–711 (2013).
Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl Acad. Sci. USA 106, 15813–15818 (2009).
Ramanan, D., Tang, M. S., Bowcutt, R., Loke, P. & Cadwell, K. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 41, 311–324 (2014).
Stappenbeck, T. S. & Virgin, H. W. Accounting for reciprocal host-microbiome interactions in experimental science. Nature 534, 191–199 (2016).
Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734 (2005).
Jing, X. et al. Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis. J. Immunol. 193, 3055–3069 (2014).
Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).
Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 38, 1290–1298 (2014).
Schulfer, A. F. et al. Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat. Microbiol. 3, 234–242 (2018).
Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224–5231 (1998).
Moran, C. J. et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 19, 115–123 (2013).
Russell, S. L. et al. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4, 158–164 (2013).
Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+and regulatory IL-10+Foxp3+RORgamma t+T cells. J. Exp. Med. 205, 1381–1393 (2008).
Lochner, M. et al. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. J. Immunol. 186, 1531–1537 (2011).
Solomon, B. D. & Hsieh, C. S. Antigen-specific development of mucosal Foxp3+RORgammat+T cells from regulatory T cell precursors. J. Immunol. 197, 3512–3519 (2016).
Yang, B. H. et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444–457 (2016).
Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564–568 (2014).
Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337–348 (2011).
Wohlfert, E. A. et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503–4515 (2011).
Ohnmacht, C. et al. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349, 989–993 (2015).
Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621–1624 (2012).
Masella, A. P., Bartram, A. K., Truszkowski, J. M., Brown, D. G. & Neufeld, J. D. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 13, 31 (2012).
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069–5072 (2006).
We thank N. Power, C. Tu, and M. Noori for their technical assistance. Grant support provided by a Canadian Institute for Health Research Team Grant (THC-13523, D.J.P., K.C.); Ontario Graduate Scholarship in Science and Technology (A.G.); Mount Sinai Hospital Dept. of Medicine Graduate Studentship Award (A.G.) and Postdoctoral Fellowship (W.T., G.Z.); and CIHR Canadian Association of Gastroenterology Fellowship (W.T., G.Z.).
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Goethel, A., Turpin, W., Rouquier, S. et al. Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure. Mucosal Immunol 12, 720–732 (2019). https://doi.org/10.1038/s41385-018-0128-y
This article is cited by
NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn’s disease
Nature Communications (2021)
Imprinting of the immune system by the microbiota early in life
Mucosal Immunology (2020)
Host genotype and early life microbiota alterations have additive effects on disease susceptibility
Mucosal Immunology (2019)
Role of microbes, metabolites and effector compounds in host–microbiota interaction: a pharmacological outlook
Environmental Chemistry Letters (2019)